CRISM Therapeutics Corporation plc (AIM: CRTX)*: Positive preclinical data for its second asset, Docetaxel-ChemoSeed in prostate cancer modelCardiogeni plc (AQSE: CGNI): Completion of share agreement with Kira Health
21 Apr 2026
SP Angel Healthcare Conditions
Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
SP Angel Healthcare Conditions
- Published:
21 Apr 2026 -
Author:
Vadim Alexandre | Greg Pave -
Pages:
3 -
CRISM Therapeutics Corporation plc (AIM: CRTX)*: Positive preclinical data for its second asset, Docetaxel-ChemoSeed in prostate cancer modelCardiogeni plc (AQSE: CGNI): Completion of share agreement with Kira Health